Eversept Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Eversept Partners's UTHR Position: Q3 2026 in Review
Eversept Partners increased its United Therapeutics (UTHR) stake by 13% in Q3 2026, buying an estimated $19.2M and bringing the position to 324,729 shares worth $176M. The position accounts for 9.46% of the portfolio, ranked #1.
Eversept Partners first reported a position in UTHR in Q2 2020 and has held it in 26 quarters since. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Eversept Partners held 324,729 shares of United Therapeutics worth $176M as of Q3 2026.
- Eversept Partners bought 37,061 United Therapeutics shares in Q3 2026, an estimated $19.2M.
- United Therapeutics made up 9.46% of Eversept Partners's portfolio in Q3 2026, its #1 holding.
- Eversept Partners first reported a position in United Therapeutics in Q2 2020 and has held it in 26 quarters since.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.